- Home
- PULM vs MBBC Comparison
PULM vs MBBC Comparison
Compare PULM & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- MBBC
- Stock Information
- Founded
- PULM 2003
- MBBC 1902
- Country
- PULM United States
- MBBC United States
- Employees
- PULM N/A
- MBBC N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- MBBC Banks
- Sector
- PULM Health Care
- MBBC Finance
- Exchange
- PULM Nasdaq
- MBBC Nasdaq
- Market Cap
- PULM 33.2M
- MBBC 29.3M
- IPO Year
- PULM N/A
- MBBC N/A
- Fundamental
- Price
- PULM $5.62
- MBBC $10.10
- Analyst Decision
- PULM
- MBBC
- Analyst Count
- PULM 0
- MBBC 0
- Target Price
- PULM N/A
- MBBC N/A
- AVG Volume (30 Days)
- PULM 11.2K
- MBBC 5.8K
- Earning Date
- PULM 08-12-2025
- MBBC 08-22-2025
- Dividend Yield
- PULM N/A
- MBBC N/A
- EPS Growth
- PULM N/A
- MBBC 103.56
- EPS
- PULM N/A
- MBBC 0.22
- Revenue
- PULM $1,921,000.00
- MBBC $6,591,743.00
- Revenue This Year
- PULM N/A
- MBBC N/A
- Revenue Next Year
- PULM $134.88
- MBBC N/A
- P/E Ratio
- PULM N/A
- MBBC $45.86
- Revenue Growth
- PULM N/A
- MBBC N/A
- 52 Week Low
- PULM $1.78
- MBBC $6.38
- 52 Week High
- PULM $10.40
- MBBC $12.00
- Technical
- Relative Strength Index (RSI)
- PULM 32.49
- MBBC N/A
- Support Level
- PULM $5.60
- MBBC N/A
- Resistance Level
- PULM $6.15
- MBBC N/A
- Average True Range (ATR)
- PULM 0.28
- MBBC 0.00
- MACD
- PULM -0.05
- MBBC 0.00
- Stochastic Oscillator
- PULM 1.63
- MBBC 0.00
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About MBBC Marathon Bancorp Inc. Common Stock
Marathon Bancorp Inc is a Wisconsin-chartered savings bank. It is a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the Company's revenues come from interest income on loans and debt securities.